RIGI and cryohydrocytosis: A growing body of evidence suggests changes in Toll-like receptor signaling pathways (e.g. blockade of TLR-3, RIG-I signaling) and expression levels of TLR mRNAs in CHC patients with or without responsiveness to antiviral therapy [30]–[36].